|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.60 USD | 0.00% |
|
0.00% | - |
| 08:34am | Nuvectis gains two experimental drugs in licensing deal with China's Haisco | RE |
| 05:42am | Storebrand Europa rose 2.89 percent in May, AI optimism boosted market performance | FW |
| Market Cap | 273B 238B 220B 206B 386B 25,767B 389B 2,619B 1,019B 12,668B 1,024B 1,002B 44,010B | P/E 2026 * |
20.3x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 305B 266B 246B 230B 432B 28,815B 435B 2,929B 1,140B 14,167B 1,145B 1,120B 49,217B | EV / Sales 2026 * |
5.35x | EV / Sales 2027 * | 4.98x |
| Free-Float |
91.66% | Yield 2026 * |
3.05% | Yield 2027 * | 3.14% |
Last Transcript: Novartis AG
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 268B | ||
| +0.67% | -2.06% | +43.53% | +141.68% | 980B | ||
| +1.04% | -2.02% | +52.58% | +39.41% | 550B | ||
| +6.23% | +3.70% | +25.04% | +67.22% | 382B | ||
| -0.06% | -3.09% | +23.33% | +16.78% | 316B | ||
| +0.42% | +0.68% | +27.54% | +14.57% | 272B | ||
| +2.39% | +5.02% | -33.44% | -44.76% | 199B | ||
| +1.98% | -2.04% | +26.04% | +49.52% | 182B | ||
| +1.01% | +0.22% | +17.31% | +59.48% | 154B | ||
| -0.58% | -3.65% | +4.25% | -35.32% | 144B | ||
| Average | +1.35% | -2.76% | +20.69% | +34.29% | 353.09B | |
| Weighted average by Cap. | +1.39% | -3.55% | +30.63% | +62.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.02B 49.82B 46.08B 43.01B 80.75B 5,388B 81.34B 548B 213B 2,649B 214B 209B 9,203B | 60.42B 52.8B 48.84B 45.58B 85.58B 5,710B 86.2B 580B 226B 2,807B 227B 222B 9,753B |
| Net income | 14.15B 12.36B 11.44B 10.67B 20.04B 1,337B 20.18B 136B 52.87B 657B 53.12B 51.97B 2,284B | 15.67B 13.69B 12.67B 11.82B 22.2B 1,481B 22.36B 151B 58.57B 728B 58.84B 57.57B 2,530B |
| Net Debt | 32.26B 28.19B 26.07B 24.34B 45.69B 3,049B 46.02B 310B 121B 1,499B 121B 118B 5,207B | 28.3B 24.73B 22.87B 21.35B 40.08B 2,674B 40.37B 272B 106B 1,315B 106B 104B 4,568B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
Select your edition
All financial news and data tailored to specific country editions


















